< Back to search
Filter
1

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Halifax, Boston MA, Lebanon NH, The Bronx NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase3, Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Rochester NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT06697600

Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase2, Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

for
Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Location: New Haven CT, New York NY, Chapel Hill NC, Tampa FL,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT06656494

Phase1, Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT05805605

Phase2, Recruiting

Interested in new acute myeloid leukemia trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

for
AML, Adult, MDS
Location: Boston MA, New York NY, Tampa FL, Cleveland OH,
Sponsor: Stelexis BioSciences

Sex: All

Age: 18+

Code: NCT06533761

Phase1, Recruiting

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

for
AML/MDS, B-ALL, T-ALL, BPDCN
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT04318678

Phase1, Recruiting

Study of APVO436 in Patients With AML or MDS

for
AML, MDS
Location: Miami FL, Gainesville FL, Greenville SC, Columbus OH,
Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase1, Recruiting

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

for
Leukemia, Myeloid, Acute
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT05945849

Phase1, Recruiting

Molecular Imaging to Capture Disease Heterogeneity in Acute Myeloid Leukemia

for
Leukemia, Myeloid, Acute
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT02682732

Recruiting

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

for
Leukemia, Myeloid Leukemia, Monocytic Leukemia
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06429449

Phase1, Recruiting

Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia

for
Relapsed Adult AML
Location: Houston TX
Sponsor: Pacylex Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06613217

Phase1, Recruiting

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation

Sex: All

Age: 65+

Code: NCT02802267

Phase2, Recruiting

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 60+

Code: NCT01515527

Phase2, Recruiting

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

for
Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06235801

Phase1, Phase2, Recruiting

IS-free Treg HaploHCT

for
Stem Cell Transplant Complications, Graft Vs Host Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT04678401

Phase1, Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

for
Stem Cell Transplantation, Myelodysplastic Syndromes,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT07469592

Recruiting

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

for
Malignancy, Hematologic, Neoplasms, Hematologic,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06904066

Phase1, Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Buffalo NY, Chicago IL
Sponsor: Marlise Luskin, MD

Sex: All

Age: 18+

Code: NCT03595917

Phase1, Recruiting

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03263572

Phase2, Recruiting